TMO · Full Picture
THERMO FISHER SCIENTIFIC INC. — the full picture
Trailing window · 2026-05-11 to 2026-08-09
One earnings window, everything merged: the filing, the call, press releases and news digests, folded into ranked threads.
What to look at first
- Revenue Performance and Mix · Revenue growth & mixPriority 44quote_verifiedThermo Fisher's chairman, president, and CEO Marc N. Casper will present at the Raymond James Institutional Investors Conference on March 3, 2026 at 9:15 a.m. ET with a live webcast on the company's investor relations website.
- Guidance / Outlook · Guidance & outlookPriority 35quote_verifiedThermo Fisher reaffirmed its fiscal 2026 EPS guidance.
- Cybersecurity Vulnerability and Patches · Cybersecurity & incidentsPriority 341 forward row(s); quote_verifiedThermo Fisher released security updates to address a critical vulnerability CVE-2026-17583 in several Applied Biosystems human identification products.
- Product Launch and Transition · Products & launchesPriority 321 forward row(s); quote_verifiedThermo Fisher Scientific introduced the new X2 and S2 Series Centrifuges, general purpose centrifuges designed for medical research, biopharma, and clinical labs.
- Research Protein Market Demand · Demand, orders & backlogPriority 29quote_verifiedThe Research Use (RUO) Recombinant Protein Market is projected to grow from USD 1.11 billion in 2026 to USD 1.55 billion by 2031 at a CAGR of 7.0%.
- Diagnostics Product Momentum · UnclassifiedPriority 28quote_verifiedSimply Wall Street reported Thermo Fisher highlighted its specialty diagnostics business including new products and FDA clearances.
- Litigation and Legal Risk · Litigation & settlementsPriority 27quote_verifiedA Thermo Fisher Statistical Science director filed a lawsuit alleging the company violated his religious rights by not providing a fossil fuel-free 401(k) investment option.
- ESG and sustainability · ESG & sustainabilityPriority 26quote_verifiedThe centrifuges incorporate GreenCool™ Technology with low Global Warming Potential and are energy-efficient.
Threads by pillar
Revenue & Demand Priority 49 · 3 threads
- Revenue Performance and MixPriority 44 · News
- Product Launch and TransitionPriority 32 · News
- Research Protein Market DemandPriority 29 · News
Legal, Regulatory & Policy Priority 27 · 1 thread
- Litigation and Legal RiskPriority 27 · News
Guidance & Outlook Priority 35 · 1 thread
- Guidance / OutlookPriority 35 · News
Management & Governance Priority 36 · 2 threads
- Cybersecurity Vulnerability and PatchesPriority 34 · News
- ESG and sustainabilityPriority 26 · News
Unclassified Priority 28 · 1 thread
- Diagnostics Product MomentumPriority 28 · News